Guenka Petrova
Guenka Petrova
Prof. Pharmacoeconomic, Pharmaceutical Legislation, Medical University of Sofia, Faculty of Pharmacy
E-mail megerősítve itt: pharmfac.net - Kezdőlap
Hivatkozott rá
Hivatkozott rá
Policies for biosimilar uptake in Europe: an overview
E Moorkens, AG Vulto, I Huys, P Dylst, B Godman, S Keuerleber, B Claus, ...
PloS one 12 (12), e0190147, 2017
Use of complementary and alternative medicine by children in Europe: published data and expert perspectives
TJ Zuzak, J Boňková, D Careddu, M Garami, A Hadjipanayis, J Jazbec, ...
Complementary therapies in medicine 21, S34-S47, 2013
The implementation of managed entry agreements in Central and Eastern Europe: findings and implications
A Ferrario, D Arāja, T Bochenek, T Čatić, D Dankó, M Dimitrova, J Fürst, ...
Pharmacoeconomics 35, 1271-1285, 2017
Barriers for access to new medicines: searching for the balance between rising costs and limited budgets
B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ...
Frontiers in Public Health 6, 328, 2018
EQ-5D in central and Eastern Europe: 2000–2015
F Rencz, L Gulácsi, M Drummond, D Golicki, V Prevolnik Rupel, J Simon, ...
Quality of Life Research 25, 2693-2710, 2016
Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria
L Gulácsi, AM Rotar, M Niewada, O Löblová, F Rencz, G Petrova, I Boncz, ...
The European journal of health economics 15, 13-25, 2014
Pricing and reimbursement of biosimilars in Central and Eastern European countries
P Kawalec, E Stawowczyk, T Tesar, J Skoupa, A Turcu-Stiolica, ...
Frontiers in pharmacology 8, 288, 2017
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
B Godman, A Hill, S Simoens, G Selke, I Selke Krulichová, ...
Expert review of pharmacoeconomics & outcomes research 21 (4), 527-540, 2021
Use of biologics for psoriasis in Central and Eastern European countries
F Rencz, L Kemény, JZ Gajdácsi, W Owczarek, P Arenberger, GS Tiplica, ...
Journal of the European Academy of Dermatology and Venereology 29 (11), 2222 …, 2015
Adaptive pathways: possible next steps for payers in preparation for their potential implementation
P Vella Bonanno, M Ermisch, B Godman, AP Martin, J Van Den Bergh, ...
Frontiers in pharmacology 8, 497, 2017
Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income …
B Godman, C Grobler, M Van-De-Lisle, J Wale, WB Barbosa, A Massele, ...
Expert opinion on pharmacotherapy 20 (18), 2237-2255, 2019
Pricing of oral generic cancer medicines in 25 European countries; findings and implications
B Godman, A Hill, S Simoens, A Kurdi, J Gulbinovič, A Martin, A Timoney, ...
Generics and Biosimilars Initiative Journal 8 (2), 49-70, 2019
Low fresh gas flow balanced anesthesia versus target controlled intravenous infusion anesthesia in laparoscopic cholecystectomy: a cost-minimization analysis
PD Stevanovic, G Petrova, B Miljkovic, R Scepanovic, R Perunovic, ...
Clinical therapeutics 30 (9), 1714-1725, 2008
Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy
G Petrova, A Stoimenova, M Dimitrova, M Kamusheva, D Petrova, ...
SAGE open medicine 5, 2050312117690404, 2017
Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria
K Tachkov, K Mitov, Y Koleva, Z Mitkova, M Kamusheva, M Dimitrova, ...
PloS one 15 (5), e0232815, 2020
Proposal for a regulation on health technology assessment in Europe–opinions of policy makers, payers and academics from the field of HTA
P Vella Bonanno, A Bucsics, S Simoens, AP Martin, W Oortwijn, ...
Expert review of pharmacoeconomics & outcomes research 19 (3), 251-261, 2019
Pharmaceutical regulation in Central and Eastern European countries: a current review
P Kawalec, T Tesar, L Vostalova, P Draganic, M Manova, A Savova, ...
Frontiers in pharmacology 8, 892, 2017
The European challenges of funding orphan medicinal products
M Szegedi, T Zelei, F Arickx, A Bucsics, E Cohn-Zanchetta, J Fürst, ...
Orphanet journal of rare diseases 13 (1), 1-8, 2018
Evaluation of consumer satisfaction using the tetra-class model
F Clerfeuille, Y Poubanne, M Vakrilova, G Petrova
Research in Social and Administrative Pharmacy 4 (3), 258-271, 2008
Complex regional pain syndrome acceptance and the alternative denominations in the medical literature
J Todorova, N Dantchev, G Petrova
Medical principles and practice 22 (3), 295-300, 2013
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20